Related references
Note: Only part of the references are listed.Alzheimer's Association Report 2015 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2015)
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model
Kuo-Hsuan Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders
Delphine Demeestere et al.
DRUG DISCOVERY TODAY (2015)
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis
Fabian D. Liechti et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
Matrix metalloproteinase 9 (MMP-9) is indispensable for long term potentiation in the central and basal but not in the lateral nucleus of the amygdala
Tomasz Gorkiewicz et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Immune aging, dysmetabolism, and inflammation in neurological diseases
Michela Deleidi et al.
FRONTIERS IN NEUROSCIENCE (2015)
Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism
V. Annese et al.
BRAIN STRUCTURE & FUNCTION (2015)
A new angle on blood-CNS interfaces: A role for connexins?
Marijke De Bock et al.
FEBS LETTERS (2014)
Matrix Metalloproteinase Inhibition Lowers Mortality and Brain Injury in Experimental Pneumococcal Meningitis
Fabian D. Liechti et al.
INFECTION AND IMMUNITY (2014)
Membrane-Type 1 Metalloproteinase Is Upregulated in Microglia/Brain Macrophages in Neurodegenerative and Neuroinflammatory Diseases
Anika Langenfurth et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
Mayank Chaturvedi et al.
MOLECULAR NEUROBIOLOGY (2014)
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
Shichun Tu et al.
MOLECULAR NEURODEGENERATION (2014)
Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation
R. E. Vandenbroucke et al.
MUCOSAL IMMUNOLOGY (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Manuel A. Friese et al.
NATURE REVIEWS NEUROLOGY (2014)
Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
Artem Kaplan et al.
NEURON (2014)
Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice
Ethan A. Winkler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
Xiang-Xiang Wang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas
Helen Koennecke et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
Roosmarijn E. Vandenbroucke et al.
EMBO MOLECULAR MEDICINE (2013)
Causes, consequences, and reversal of immune system aging
Encarnacion Montecino-Rodriguez et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Multiple sclerosis is primarily a neurodegenerative disease
Abhijit Chaudhuri
JOURNAL OF NEURAL TRANSMISSION (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain
Yang Liu et al.
NEUROBIOLOGY OF AGING (2013)
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
A. Chio et al.
NEUROEPIDEMIOLOGY (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
Association Studies of MMP-9 in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Xianghua He et al.
PLOS ONE (2013)
Relationship Between Cyclophilin A Levels and Matrix Metalloproteinase 9 Activity in Cerebrospinal Fluid of Cognitively Normal Apolipoprotein E4 Carriers and Blood-Brain Barrier Breakdown
Matthew R. Halliday et al.
JAMA NEUROLOGY (2013)
Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke
Shaheen E. Lakhan et al.
FRONTIERS IN NEUROLOGY (2013)
The Interaction of Amyloid β and the Receptor for Advanced Glycation Endproducts Induces Matrix Metalloproteinase-2 Expression in Brain Endothelial Cells
Huan Du et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Ageing as a Risk Factor for Disease
Teresa Niccoli et al.
CURRENT BIOLOGY (2012)
Molecular Pathology in Neurodegenerative Diseases
Alexander H. Peden et al.
CURRENT DRUG TARGETS (2012)
On the 'classification' of neurodegenerative disorders: discrete entities, overlap or continuum?
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2012)
MMP9: A novel function in synaptic plasticity
Magdalena Dziembowska et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inflammasome-Derived IL-1β Regulates the Production of GM-CSF by CD4+ T Cells and γδ T Cells
John R. Lukens et al.
JOURNAL OF IMMUNOLOGY (2012)
Aβ1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
Sun-Young Kook et al.
JOURNAL OF NEUROSCIENCE (2012)
Matrix Metalloprotease 8-Dependent Extracellular Matrix Cleavage at the Blood-CSF Barrier Contributes to Lethality during Systemic Inflammatory Diseases
Roosmarijn E. Vandenbroucke et al.
JOURNAL OF NEUROSCIENCE (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
Synaptic circuit remodelling by matrix metalloproteinases in health and disease
George W. Huntley
NATURE REVIEWS NEUROSCIENCE (2012)
Disruption of central nervous system barriers in multiple sclerosis
Jorge Ivan Alvarez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Amyotrophic lateral sclerosis: A neurovascular disease
Svitlana Garbuzova-Davis et al.
BRAIN RESEARCH (2011)
Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
Wenjun Li et al.
BRAIN RESEARCH (2011)
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Evelin L. Schaeffer et al.
CLINICS (2011)
Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
Vincenzo Pizza et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Biological role of matrix metalloproteinases: a critical balance
S. Loeffek et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
SERIES MATRIX METALLOPROTEINASES IN LUNG HEALTH AND DISEASE'' A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
R. E. Vandenbroucke et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Catherine Larochelle et al.
FEBS LETTERS (2011)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways
Vivek Swarup et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Disruption of Neurovascular Unit Prior to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis
Kazunori Miyazaki et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Matrix Metalloproteinase Inhibitors Attenuate Neuroinflammation Following Focal Cerebral Ischemia in Mice
Cheol Hong Park et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2011)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zlokovic
NATURE REVIEWS NEUROSCIENCE (2011)
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Velandai Srikanth et al.
NEUROBIOLOGY OF AGING (2011)
Natural History of Multiple Sclerosis: Early Prognostic Factors
Ellen M. Mowry
NEUROLOGIC CLINICS (2011)
Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease
J. Duran-Vilaregut et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
TIME-COURSE OF NIGROSTRIATAL NEURODEGENERATION AND NEUROINFLAMMATION IN THE 6-HYDROXYDOPAMINE-INDUCED AXONAL AND TERMINAL LESION MODELS OF PARKINSON'S DISEASE IN THE RAT
S. Walsh et al.
NEUROSCIENCE (2011)
Alzheimer's Disease: β-Amyloid Plaque Formation in Human Brain
Philip Seeman et al.
SYNAPSE (2011)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
C. Barcia et al.
CELL DEATH & DISEASE (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Fluids and barriers of the CNS: a historical viewpoint
Shane A. Liddelow
FLUIDS AND BARRIERS OF THE CNS (2011)
The Declining Infrastructure of the Aging Brain
David H. Salat
BRAIN CONNECTIVITY (2011)
Long-Term Expression of Tissue-Inhibitor of Matrix Metalloproteinase-1 in the Murine Central Nervous System Does Not Alter the Morphological and Behavioral Phenotype but Alleviates the Course of Experimental Allergic Encephalomyelitis
Gioia E. M. Althoff et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
I. Niebroj-Dobosz et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
Solveig Horstmann et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
Sanjay W. Pimplikar et al.
JOURNAL OF NEUROSCIENCE (2010)
Reimagining Alzheimer's Disease-An Age-Based Hypothesis
Karl Herrup
JOURNAL OF NEUROSCIENCE (2010)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Association of matrix metalloproteinases with MRI indices of brain ischemia and aging
Jose Rafael Romero et al.
NEUROBIOLOGY OF AGING (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice
Cynthia P. W. Soon et al.
NEUROMUSCULAR DISORDERS (2010)
Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
John P. Miller et al.
NEURON (2010)
Multiple brain pathologies in dementia are common
M. Woodward et al.
EUROPEAN GERIATRIC MEDICINE (2010)
The impact of the extracellular matrix on inflammation
Lydia Sorokin
NATURE REVIEWS IMMUNOLOGY (2010)
Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2009)
Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants
Sang-Kyu Park et al.
AGING CELL (2009)
Debris clearance by microglia: an essential link between degeneration and regeneration
H. Neumann et al.
BRAIN (2009)
Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases
Johannes Levin et al.
EXPERIMENTAL NEUROLOGY (2009)
Disruptions of Occludin and Claudin-5 in Brain Endothelial Cells In Vitro and in Brains of Mice with Acute Liver Failure
Feng Chen et al.
HEPATOLOGY (2009)
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice
Monica Garcia-Alloza et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling
Piotr Michaluk et al.
JOURNAL OF NEUROSCIENCE (2009)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Linking neuron and skin: Matrix metalloproteinases in amyotrophic lateral sclerosis (ALS)
Lubin Fang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Gary A. Rosenberg
LANCET NEUROLOGY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS
J. S. Henkel et al.
NEUROLOGY (2009)
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni et al.
NEUROREPORT (2009)
DIVERSE ROLES OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASES IN NEUROINFLAMMATION AND CEREBRAL ISCHEMIA
E. Candelario-Jalil et al.
NEUROSCIENCE (2009)
Matrix metalloproteinases-2 and-3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels
Reinhilde Mlekusch et al.
NEUROSCIENCE LETTERS (2009)
Amyotrophic lateral sclerosis
Lokesh C. Wijesekera et al.
ORPHANET JOURNAL OF RARE DISEASES (2009)
Neuroinflammation in the living brain of Parkinson's disease
Yasuomi Ouchi et al.
PARKINSONISM & RELATED DISORDERS (2009)
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Maria Clara Pott Godoy et al.
BRAIN (2008)
Non-motor symptoms in Parkinson's disease
W. Poewe
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia
Moon-Sook Woo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
D. H. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Perivascular Spaces and the Two Steps to Neuroinflammation
Trevor Owens et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Jose A. Obeso et al.
MOVEMENT DISORDERS (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Stefan Lorenzl et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
Inflammation as a causative factor in the aetiology of Parkinson's disease
P. S. Whitton
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A biochemical model of matrix metalloproteinase 9 activation and inhibition
Prakash Vempati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision
Sonya Vasto et al.
PHARMACOGENOMICS (2007)
Advanced glycation end products, oxidative stress and metalloproteinases are altered in the cerebral microvasculature during aging
Florentina Safciuc et al.
CURRENT NEUROVASCULAR RESEARCH (2007)
Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation
Nuria Benseny-Cases et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Control of matrix metalloproteinase catalytic activity
Hyun-Jeong Ra et al.
MATRIX BIOLOGY (2007)
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2007)
Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis
L. Morgan et al.
NEUROSCIENCE (2007)
Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers
Oleg Butovsky et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-P stimulation via the PI3K/Akt pathway
Sachiko Ito et al.
EXPERIMENTAL GERONTOLOGY (2007)
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Jialiang Hu et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Ennio Esposito et al.
EXPERIMENTAL NEUROLOGY (2007)
Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei et al.
EXPERIMENTAL NEUROLOGY (2007)
The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases
Benedicte Cauwe et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia
Robert K. Nuttall et al.
GLIA (2007)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
The dual personalities of matrix metalloproteinases in inflammation
Nghia T. V. Le et al.
FRONTIERS IN BIOSCIENCE (2007)
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
Claudio Franceschi et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Natural history of multiple sclerosis: risk factors and prognostic indicators
Sandra Vukusic et al.
CURRENT OPINION IN NEUROLOGY (2007)
Microglia instruct subventricular zone neurogenesis
Noah M. Walton et al.
GLIA (2006)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation
Kate J. Gurney et al.
NEUROBIOLOGY OF DISEASE (2006)
Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity
Anthony R. White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain
Y Gasche et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity
SE Meighan et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Microglia in the aging brain
Jessica R. Conde et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and-12 null mice
PH Larsen et al.
JOURNAL OF NEUROSCIENCE (2006)
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
V Nagy et al.
JOURNAL OF NEUROSCIENCE (2006)
Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation
AM Deschamps et al.
CARDIOVASCULAR RESEARCH (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases
Qing-Xiang Amy Sang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Overlap between neurodegenerative disorders
RA Armstrong et al.
NEUROPATHOLOGY (2005)
Multiple roles for MMPs and TIMPs in cerebral ischemia
LA Cunningham et al.
GLIA (2005)
Matrix metalloproteinase-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia
YS Kim et al.
JOURNAL OF NEUROSCIENCE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
AC Newby
PHYSIOLOGICAL REVIEWS (2005)
The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis
M Demestre et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Matrix metalloproteinase-9, its tissue inhibitor (TIMP)-1 and CRP in Alzheimer's disease
M Inspector et al.
EUROPEAN NEUROLOGY (2005)
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis:: an [11C](R)-PK11195 positron emission tomography study
MR Turner et al.
NEUROBIOLOGY OF DISEASE (2004)
α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis
M Morini et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Neutralizing antibodies against IFN-β in multiple sclerosis:: antagonization of IFN-β mediated suppression of MMPs
F Gilli et al.
BRAIN (2004)
Interaction between matrix metalloproteinase 3 and the ε4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns
MS Saarela et al.
NEUROSCIENCE LETTERS (2004)
Enzyme-replacement therapy for metabolic storage disorders
RO Brady et al.
LANCET NEUROLOGY (2004)
The promise of minocycline in neurology
VW Yong et al.
LANCET NEUROLOGY (2004)
Alzheimer disease pathology in amyotrophic lateral sclerosis
RL Hamilton et al.
ACTA NEUROPATHOLOGICA (2004)
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
S Lorenzl et al.
NEUROMOLECULAR MEDICINE (2004)
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease
JC Adair et al.
STROKE (2004)
Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates
EM Tam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Migration and differentiation of neural precursor cells can be directed by microglia
J Aarum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease
HM Gao et al.
FASEB JOURNAL (2003)
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
DC Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
β-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes
S Deb et al.
BRAIN RESEARCH (2003)
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
S Lorenzl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Aging, amyloid, and Alzheimer's disease: A perspective in honor of Carl Cotman
DJ Selkoe
NEUROCHEMICAL RESEARCH (2003)
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
PL McGeer et al.
ANNALS OF NEUROLOGY (2003)
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics
L Zecca et al.
TRENDS IN NEUROSCIENCES (2003)
Microglia as neuroprotective, immunocompetent cells of the CNS
WJ Streit
GLIA (2002)
Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
LY Qin et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease
S Lorenzl et al.
EXPERIMENTAL NEUROLOGY (2002)
Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis
GH Marracci et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
The worldwide prevalence of multiple sclerosis
M Pugliatti et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2002)
Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease
HM Gao et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases
TA Newman et al.
BRAIN (2001)
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
RLP Lindberg et al.
BRAIN (2001)
In-vivo measurement of activated microglia in dementia
A Cagnin et al.
LANCET (2001)
Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation
T Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Multiple sclerosis:: elevated expression of matrix metalloproteinases in blood monocytes
M Kouwenhoven et al.
JOURNAL OF AUTOIMMUNITY (2001)
The significance of tau and α-synuclein inclusions in neurodegenerative diseases
M Goedert
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)
An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice
SM Ye et al.
NEUROIMMUNOMODULATION (2001)
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2
C Knott et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis
W Beuche et al.
NEUROREPORT (2000)
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
A Leake et al.
NEUROSCIENCE LETTERS (2000)
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis
A Ishizuya-Oka et al.
JOURNAL OF CELL BIOLOGY (2000)
The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system
AJ Herrera et al.
NEUROBIOLOGY OF DISEASE (2000)
Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: Comparison with non-demented cases and Alzheimer's disease
RA Armstrong et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2000)
Microglial proliferation in the spinal cord of aged rats with a sciatic nerve injury
SL Stuesse et al.
NEUROSCIENCE LETTERS (2000)
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis
SL Leib et al.
INFECTION AND IMMUNITY (2000)
Neuropathological diagnosis of neurodegenerative and dementing disorders
HA Kretzschmar et al.
PATHOLOGE (2000)
Share Paper
